RAC conditionally approves lung cancer gene therapy.
Jenks
S
S
D002289:Carcinoma, Non-Small-Cell Lung / Q000628:therapy*; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000009:adverse effects*; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*; D009316:National Institutes of Health (U.S.); D014481:United States